Psychedelics Kentucky to invest US$42M in psychedelics research for opioid use disorders The money will come from the state's opioid settlement funds and the research will focus on ibogaine Rowan DunneJune 5, 2023
Psychedelics Beond publishes ‘Ibogaine: A Clinical Summary’ Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance Rowan DunneAugust 31, 2022
Culture Becoming light through the darkness: My first ibogaine trip Writer Suzannah Weiss details her experience of physical and mental healing, accompanied by comic illustrations Suzannah WeissMay 14, 2021
Analysis What happened to Canada’s ibogaine clinics? Following a surge of interest, ibogaine therapy in the country disappeared. But recent signs show regulators are warming to the promising plant Suzannah WeissDecember 23, 2020